Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-016007
Filing Date
2013-03-11
Accepted
2013-03-11 16:42:39
Documents
1
Period of Report
2013-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd373617.html 4  
1 FORM 4 rrd373617.xml 4 3781
  Complete submission text file 0001181431-13-016007.txt   5105
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Issuer) CIK: 0001356857 (see all company filings)

EIN.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO CA 92121
Business Address
Finn John (Reporting) CIK: 0001479788 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 13681287